GlassScriptPhysician profile
Leopoldo Puga
NPI 1659312536
$9,916.65
in general payments reported to CMS, 2019-2025
41 companies · $2,270 in 2025
The $2,270 reported for 2025 was more than what 85% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $757 · 2020: $653 · 2021: $1,030 · 2022: $1,572 · 2023: $1,985 · 2024: $1,649 · 2025: $2,270.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,864 · Travel and Lodging: $1,040.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,864.19 |
| Travel and Lodging | $1,039.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,727.39 | 2021-2025 | Aveir, Jot Dx, Gallant |
| Novartis Pharmaceuticals Corporation | $935.11 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $895.47 | 2019-2025 | Farxiga, Wainua |
| Merck Sharp & Dohme LLC | $874.29 | 2021-2025 | Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $539.48 | 2019-2025 | Lifevest |
| Boston Scientific Corporation | $499.93 | 2019-2025 | Watchman Flx |
| Amgen INC. | $472.26 | 2021-2025 | Repatha, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $464.78 | 2019-2025 | Jardiance |
| Cvrx, INC. | $356.84 | 2022-2024 | Barostim Neo System |
| Cardiva Medical, INC. | $354.67 | 2023 | Cardiva Vascade 6/7f Vcs |
| Pfizer INC. | $319.50 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $262.03 | 2021-2025 | |
| Medtronic, INC. | $211.12 | 2021-2023 | Reveal Linq, Contour 3d, Mycarelink |
| E.R. Squibb & Sons, L.L.C. | $189.34 | 2019-2025 | Camzyos, Eliquis |
| Kestra Medical Technology Services, INC. | $174.95 | 2024-2025 | Assure Wcd |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $169.27 | 2019-2020 | |
| Akcea Therapeutics, INC. | $143.95 | 2019-2020 | |
| Scpharmaceuticals INC. | $135.27 | 2023-2024 | |
| Kiniksa Pharmaceuticals International, Plc | $135.19 | 2024 | Arcalyst |
| Alnylam Pharmaceuticals INC. | $114.67 | 2021-2025 | Amvuttra |
| Abiomed | $114.57 | 2024-2025 | Impella |
| Edwards Lifesciences Corporation | $96.56 | 2020-2025 | Pascal |
| Irhythm Technologies, INC. | $87.47 | 2021-2023 | Zio Xt Patch |
| Janssen Pharmaceuticals, INC | $85.38 | 2019-2024 | Xarelto |
| Lexicon Pharmaceuticals, INC. | $85.10 | 2023-2024 | Inpefa |
| Kowa Pharmaceuticals America, INC. | $84.25 | 2020 | |
| Novo Nordisk INC | $54.13 | 2023-2025 | |
| Inspire Medical Systems, INC. | $46.45 | 2024-2025 | Inspire |
| Actelion Pharmaceuticals US, INC. | $41.46 | 2023 | Uptravi |
| Amarin Pharma, INC. | $32.50 | 2019-2020 | |
| Heartflow, INC. | $30.17 | 2025 | |
| Kiniksa Pharmaceuticals, LTD. | $21.72 | 2023 | Arcalyst |
| Shockwave Medical, INC | $21.03 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Sanofi-Aventis U.S. LLC | $20.72 | 2019 | |
| Philips North America LLC | $20.55 | 2024 | (5044) Mcot |
| Altathera Pharmaceuticals LLC | $19.97 | 2024 | Sotalol Hydrochloride |
| Angiodynamics, INC. | $17.56 | 2024 | Auryon Laser System 100-120 Vac |
| Tactile Systems Technology INC | $16.46 | 2021 | |
| Braemar Manufacturing, LLC | $16.37 | 2019 | |
| Esperion Therapeutics, INC. | $14.55 | 2025 | Nexletol |
| Cardiovascular Systems INC. | $14.17 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leopoldo Puga listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.